ARTICLE | Company News

Cytel deal

November 7, 1994 8:00 AM UTC

Cylexin is in Phase II trials in acute lung injury following PTE, a surgical procedure in which blood vessels in the lungs are opened and clots removed. CYTL plans to initiate Phase II trials shortly in reperfusion injury after myocardial infarction. ...